A new frontier in temporomandibular joint osteoarthritis treatment: Exosome-based therapeutic strategy
Temporomandibular joint osteoarthritis (TMJOA) is a debilitating degenerative disease with high incidence, deteriorating quality of patient life. Currently, due to ambiguous etiology, the traditional clinical strategies of TMJOA emphasize on symptomatic treatments such as pain relief and inflammatio...
Main Authors: | Wenxiu Yuan, Yange Wu, Maotuan Huang, Xueman Zhou, Jiaqi Liu, Yating Yi, Jun Wang, Jin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.1074536/full |
Similar Items
-
Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis
by: Zehao Zhang, et al.
Published: (2023-09-01) -
Strontium–Alix interaction enhances exosomal miRNA selectively loading in synovial MSCs for temporomandibular joint osteoarthritis treatment
by: Wenxiu Yuan, et al.
Published: (2025-02-01) -
Interdisciplinary Approach to the Temporomandibular Joint Osteoarthritis—Review of the Literature
by: Marcin Derwich, et al.
Published: (2020-05-01) -
Osteoarthritis of the Temporomandibular Joint: A Narrative Overview
by: Caroline Mélou, et al.
Published: (2022-12-01) -
Burn-synovectomy mouse model for temporomandibular joint osteoarthritis
by: Ginny Ching-Yun Hsu
Published: (2024-03-01)